Search - tctmd.com

Displaying 241 - 260 of 692

Sort: Relevancy | Date

Presentation TCT 2017

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Presenter: Charles J. Davidson, Mathew Williams, Julia Seeger

November 01, 2017

Presentation TCT 2017

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Presenter: Charles J. Davidson, Mathew Williams, Albert Markus Kasel

November 01, 2017

Presentation TCT 2017

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Presenter: Charles J. Davidson, Mathew Williams, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

Presenter: Charles J. Davidson, Mathew Williams, Luis Nombela-Franco

November 01, 2017

Presentation TCT 2017

Acute and Chronic Right-Sided Support

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

Syncardia: Progress With a Total Artificial Heart

Presenter: Francisco A Arabía

November 01, 2017

Presentation TCT 2017

How to Manage a Stroke After TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Stephen R. Ramee

November 01, 2017

Presentation TCT 2017

Heart Assist 5: Continuous, Remote Flow Monitoring

Presenter: Valluvan Jeevanandam

November 01, 2017

Presentation TCT 2017

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Steven J. Yakubov

November 01, 2017

Presentation TCT 2017

Heart Mate III: Has the Problem of Thrombus Been Solved?

Presenter: Nir Uriel

November 01, 2017

Presentation TCT 2017

How to Manage Severe LVOT Calcium With TAVR

Presenter: Torsten P. Vahl, Mathew Williams

November 01, 2017

Presentation TCT 2017

HVAD/MVAD/CircuLite Update

Presenter: Daniel Burkhoff

November 01, 2017

Presentation TCT 2017

How to Diagnose and Manage Moderate or Severe PVL after TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Omar K. Khalique

November 01, 2017

Presentation TCT 2017

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

Presenter: Ulrich P. Jorde

November 01, 2017

Presentation TCT 2017

How to Manage Coronary Obstruction (Threatened or Actual) During TAVR

Presenter: Torsten P. Vahl, Mathew Williams

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Chronic Kidney Disease

Presenter: Gregory P. Fontana, Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

Aortic Arch Electrical Stimulation for Heart Failure

Presenter: Jozef Bartunek

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

Presenter: Gregory P. Fontana, Alexander Lauten

November 01, 2017

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Presenter: Gregory P. Fontana, Julinda Mehilli

November 01, 2017

Advertisement

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

Acute and Chronic Right-Sided Support

Syncardia: Progress With a Total Artificial Heart

How to Manage a Stroke After TAVR

Heart Assist 5: Continuous, Remote Flow Monitoring

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

Heart Mate III: Has the Problem of Thrombus Been Solved?

How to Manage Severe LVOT Calcium With TAVR

HVAD/MVAD/CircuLite Update

How to Diagnose and Manage Moderate or Severe PVL after TAVR

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

How to Manage Coronary Obstruction (Threatened or Actual) During TAVR

TAVR for Severe AS and Chronic Kidney Disease

Aortic Arch Electrical Stimulation for Heart Failure

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

The Potential for Neuromodulation in Heart Failure

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content